These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35834373)

  • 1. Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care: cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in England.
    Hill NR; Groves L; Dickerson C; Boyce R; Lawton S; Hurst M; Pollock KG; Sugrue DM; Lister S; Arden C; Davies DW; Martin AC; Sandler B; Gordon J; Farooqui U; Clifton D; Mallen C; Rogers J; Camm AJ; Cohen AT
    J Med Econ; 2022; 25(1):974-983. PubMed ID: 35834373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: evaluation of a machine learning risk prediction algorithm.
    Hill NR; Sandler B; Mokgokong R; Lister S; Ward T; Boyce R; Farooqui U; Gordon J
    J Med Econ; 2020 Apr; 23(4):386-393. PubMed ID: 31855091
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of undiagnosed atrial fibrillation patients using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI): Study protocol for a randomised controlled trial.
    Hill NR; Arden C; Beresford-Hulme L; Camm AJ; Clifton D; Davies DW; Farooqui U; Gordon J; Groves L; Hurst M; Lawton S; Lister S; Mallen C; Martin AC; McEwan P; Pollock KG; Rogers J; Sandler B; Sugrue DM; Cohen AT
    Contemp Clin Trials; 2020 Dec; 99():106191. PubMed ID: 33091585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of undiagnosed atrial fibrillation using a machine learning risk-prediction algorithm and diagnostic testing (PULsE-AI) in primary care: a multi-centre randomized controlled trial in England.
    Hill NR; Groves L; Dickerson C; Ochs A; Pang D; Lawton S; Hurst M; Pollock KG; Sugrue DM; Tsang C; Arden C; Wyn Davies D; Martin AC; Sandler B; Gordon J; Farooqui U; Clifton D; Mallen C; Rogers J; Camm AJ; Cohen AT
    Eur Heart J Digit Health; 2022 Jun; 3(2):195-204. PubMed ID: 36713002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.
    Welton NJ; McAleenan A; Thom HH; Davies P; Hollingworth W; Higgins JP; Okoli G; Sterne JA; Feder G; Eaton D; Hingorani A; Fawsitt C; Lobban T; Bryden P; Richards A; Sofat R
    Health Technol Assess; 2017 May; 21(29):1-236. PubMed ID: 28629510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
    Hobbs FD; Fitzmaurice DA; Mant J; Murray E; Jowett S; Bryan S; Raftery J; Davies M; Lip G
    Health Technol Assess; 2005 Oct; 9(40):iii-iv, ix-x, 1-74. PubMed ID: 16202350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?
    Tarride JE; Quinn FR; Blackhouse G; Sandhu RK; Burke N; Gladstone DJ; Ivers NM; Dolovich L; Thornton A; Nakamya J; Ramasundarahettige C; Frydrych PA; Henein S; Ng K; Congdon V; Birtwhistle RV; Ward R; Healey JS
    Can J Cardiol; 2018 Nov; 34(11):1522-1525. PubMed ID: 30144961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.
    Jacobs MS; Kaasenbrood F; Postma MJ; van Hulst M; Tieleman RG
    Europace; 2018 Jan; 20(1):12-18. PubMed ID: 27733465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of systematic screening for the detection of atrial fibrillation.
    Moran PS; Flattery MJ; Teljeur C; Ryan M; Smith SM
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009586. PubMed ID: 23633374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable Devices.
    Chen W; Khurshid S; Singer DE; Atlas SJ; Ashburner JM; Ellinor PT; McManus DD; Lubitz SA; Chhatwal J
    JAMA Health Forum; 2022 Aug; 3(8):e222419. PubMed ID: 36003419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation.
    Simpson E; Stevenson M; Scope A; Poku E; Minton J; Evans P
    Health Technol Assess; 2013 Aug; 17(36):1-263, v-vi. PubMed ID: 23985296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation.
    Duarte R; Stainthorpe A; Mahon J; Greenhalgh J; Richardson M; Nevitt S; Kotas E; Boland A; Thom H; Marshall T; Hall M; Takwoingi Y
    PLoS One; 2019; 14(12):e0226671. PubMed ID: 31869370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease.
    Ruiz Vargas E; Sposato LA; Lee SAW; Hachinski V; Cipriano LE
    Stroke; 2018 Dec; 49(12):2844-2850. PubMed ID: 30571418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of one-time opportunistic screening for atrial fibrillation in different age cohorts of inhabitants in Denmark aged 65 years and above: a Markov modelled analysis.
    Sciera LK; Frost L; Dybro L; Poulsen PB
    Eur Heart J Qual Care Clin Outcomes; 2022 Mar; 8(2):177-186. PubMed ID: 33337469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.
    Lowres N; Neubeck L; Salkeld G; Krass I; McLachlan AJ; Redfern J; Bennett AA; Briffa T; Bauman A; Martinez C; Wallenhorst C; Lau JK; Brieger DB; Sy RW; Freedman SB
    Thromb Haemost; 2014 Jun; 111(6):1167-76. PubMed ID: 24687081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
    Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS Study.
    Reynolds MR; Stein AB; Sun X; Hytopoulos E; Steinhubl SR; Cohen DJ
    Circ Cardiovasc Qual Outcomes; 2023 Nov; 16(11):e009751. PubMed ID: 37905421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for atrial fibrillation in patients aged 65 years or over attending annual flu vaccination clinics at a single general practice.
    Rhys GC; Azhar MF; Foster A
    Qual Prim Care; 2013; 21(2):131-40. PubMed ID: 23735694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.